Delivery Order SPE2D119D7007-SPE2D520F5788
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Datex-Ohmeda, Inc., a subsidiary of General Electric Company (GE). The contract, valued at $53,434.88, is for the delivery of a Model 259CX patient monitor with Masimo MSPO2 technology. This is a Firm Fixed Price delivery order and does not utilize a small business set-aside. Datex-Ohmeda, a major supplier of medical equipment to federal agencies, has an established presence in the government market, having...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Datex-Ohmeda, Inc., a subsidiary of General Electric Company (GE) operating under the GE Healthcare Bioscience Bioprocess trade name. The contract is for the delivery of CORO 259CX medical device bundles, with a potential value of $30,720.00 and a period of performance through March 15, 2024. Datex-Ohmeda is a manufacturer of bioprocessing equipment, patient monitoring systems,...
- This federal contract award, valued at $139,776.68, was issued by the Defense Logistics Agency (DLA) to Datex-Ohmeda, Inc., a subsidiary of Danaher Corporation. The contract is a delivery order under the DLA Medical Supply Chain Master IDIQ contract, for the procurement of medical capital equipment. Datex-Ohmeda, doing business as GE Healthcare Bioscience Bioprocess, is a manufacturer of a wide range of medical technologies and services, including patient monitoring systems, anesthesia machines,...
- Datex-Ohmeda, Inc. (doing business as GE Healthcare), a subsidiary of General Electric Company, was awarded a delivery order valued at $13,358.72 for a Model 259CX with Masimo SpO2 US Build medical device on September 5, 2024. This firm fixed-price contract, funded by the Defense Logistics Agency's Medical Supply Chain division, was completed on October 18, 2024, with performance conducted in Madison, Wisconsin. The award was not designated as a set-aside contract, reflecting Datex-Ohmeda's...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Datex-Ohmeda, Inc., a subsidiary of General Electric Company (GE). The $1,845.00 firm fixed-price contract is for the delivery of specialized medical equipment, supplies, and maintenance services, including patient monitoring systems, anesthesia machines, and neonatal intensive care unit (NICU) equipment. The contract does not utilize a small business set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Datex-Ohmeda, Inc. (doing business as GE Healthcare Bioscience Bioprocess), a subsidiary of Danaher Corporation. The order, valued at $144,672.00, is for the delivery of unspecified medical components and supplies. Datex-Ohmeda is a manufacturer of healthcare products and services, including bioprocessing equipment, patient monitoring systems, and medical imaging...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Datex-Ohmeda, Inc., a subsidiary of General Electric Company (GE). The contract, valued at $147,749.00, is for the provision of medical equipment and supplies, including anesthesia machines, patient monitors, neonatal intensive care unit (NICU) equipment, and other advanced medical devices. Datex-Ohmeda, a major supplier to the U.S. government, has received numerous federal contract awards from...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Datex-Ohmeda, Inc., doing business as GE Healthcare Bioscience Bioprocess, a division of General Electric Company. The contract has a potential value of $118,856.00 and is a firm fixed price award with no set-aside designation. Datex-Ohmeda is providing medical equipment and supplies to support healthcare programs, including items such as anesthesia machines, patient monitoring systems, and...
- This is a $84,484.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Datex-Ohmeda, Inc., doing business as GE Healthcare Bioscience Bioprocess. The order is part of the DLA Medical Capital Equipment Program, which provides a pre-negotiated contract vehicle for federal agencies to acquire a range of advanced medical technologies, including diagnostic imaging products, patient monitoring systems, anesthesia equipment, and cardiac diagnostic...
- This federal contract award to Datex-Ohmeda, Inc., a subsidiary of General Electric Company, is for the delivery of medical equipment and supplies to the Defense Logistics Agency, a component of the U.S. Department of Defense. The $23,725.00 firm fixed-price delivery order includes products such as anesthesia machines, patient monitoring systems, neonatal intensive care unit (NICU) equipment, and other advanced medical devices. Datex-Ohmeda is a large business entity and this contract does not...
- SPE2D119D7007Indefinite Delivery Contract
- SPE2D119D7007-SPE2D520F5788Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Datex-Ohmeda, Inc., a subsidiary of General Electric Company (GE). The contract is for the delivery of a patient monitoring device, Model 259CX with Masimo MSPO2 US Build, at a total potential value of $163,497.36. No small business set-aside was used for this award. Datex-Ohmeda is a major manufacturer and provider of medical technologies and services, including bioprocessing equipment, patient monitoring systems, and diagnostic imaging products. As both a prime contractor and subcontractor, Datex-Ohmeda has a substantial history of furnishing specialized medical equipment and services to federal agencies such as the Department of Veterans Affairs (VA) and Indian Health Service, as well as the DLA Troop Support Medical division under various contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $163.5k | 2/25/20 |